Navigation Links
The European Commission Grants Marketing Authorization for DIFICLIR™ (fidaxomicin) Tablets for Treatment of Clostridium difficile Infections
Date:12/12/2011

SAN DIEGO, Dec. 12, 2011 /PRNewswire/ -- Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) and Astellas Pharma Europe Ltd., a European subsidiary of Tokyo-based Astellas Pharma Inc. (Tokyo: 4503) announced today that the European Commission has granted Marketing Authorization (MA) for DIFICLIR™ (fidaxomicin) tablets for the treatment of adults with Clostridium difficile infections (CDI) also known as Clostridium difficile-associated diarrhea (CDAD). CDI is a significant problem in hospitals and long-term care facilities all over the world. EMA approval was based on two large, multi-national, Phase 3 clinical trials that demonstrated that DIFICLIR was as effective as oral vancomycin in treating CDI. DIFICLIR had a significantly lower rate of recurrence (including relapses) compared to vancomycin in the 30 days following treatment.  DIFICLIR is the only drug approved by the EMA proven to significantly lower the rate of recurrence of CDI compared to oral vancomycin. The clinical trials included patients over the age of 65 and those taking concomitant antibiotics to treat multiple infections.

"The European approval is a key step in making fidaxomicin more widely available to patients across the globe to treat this very serious disease," said Pedro Lichtinger, President and Chief Executive Officer of Optimer. "We believe we have obtained a very strong label recognizing the benefits of DIFICLIR versus vancomycin, including significant reductions in recurrence."

The European approval affirms the recent positive opinion from the Committee of Medicinal Products for Human Use (CHMP) and is based on two Phase 3 clinical trials that were conducted to ensure the safety and efficacy of 400mg/day DIFICLIR (fidaxomicin) tablets compared to 500mg/day oral vancomycin for 10 days in subjects with CDI. The first Phase 3 study was carried out in 629 subjects in No
'/>"/>

SOURCE Optimer Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. ULURU Inc. Extends the European Altrazeal® License to Include Australia and New Zealand
2. Ampio Pharmaceuticals Awarded European Patent that Strengthens Intellectual Property Protection for its key drug Ampion™
3. Avanafil Data Presented at the European Society of Sexual Medicine Meeting
4. European Medicines Agencys (EMA) Committee for Human Medicinal Products (CHMP)Tentatively Scheduled to Render an Opinion on PixuvriTM Marketing Authorization Application on January 19, 2012
5. CardioInsight Announces CE Mark Clearance and European Launch of the ECVUE™ Non-Invasive Electrocardiographic Mapping System
6. Omeros Announces Submission to European Medicines Agency of Paediatric Investigation Plan Letter of Intent for OMS302
7. Delcath Announces Agreement With European Institute of Oncology for Initial Launch of Hepatic Chemosat Delivery System in the European Union
8. X-ray Equipment - Top 5 European Markets
9. Amsterdam Molecular Therapeutics Receives Orphan Designation in the European Union for Hemophilia B Gene Therapy
10. RSB Spine, LLC, Announces European Patent Allowance
11. Vectibix® (Panitumumab) Granted Approval for Expanded Indications in the European Union
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... Nov. 21, 2014  Lexicon Pharmaceuticals, Inc. (Nasdaq: ... its offering of $80,000,000 aggregate principal amount of 5.25% ... a private offering within the United States ... institutional buyers pursuant to Rule 144A under the Securities ... has also granted the initial purchasers an option to ...
(Date:11/18/2014)... 2014 Breast cancer will interrupt life ... who get a new diagnosis. The Commission for ... case managers to help those diagnosed with advanced ... physical, emotional and financial decisions that come with ... cost via the Commission,s online knowledge resource, the ...
(Date:11/18/2014)... , Nov. 18, 2014 BioLink ... International Technology Transfer Summit, co-organized by CCCMHPIE ( ... Export of Medicines & Health Products), UBM Live ... January 22nd and 23rd, 2015 at Beijing Yizhuang Biomedical ...   This event will gather ...
Breaking Medicine Technology:Lexicon Announces Pricing Of Convertible Senior Notes Offering 2Lexicon Announces Pricing Of Convertible Senior Notes Offering 3New Breast Cancer Resources: Commission For Case Manager Certification Adds Specialty Tools to Case Management Body of Knowledge Online Learning Center 2BioLink 2015 Will be Held on Jan 22, 2015, with a Focus on Biopharma Industrial Innovation & International Technology Transfer 2BioLink 2015 Will be Held on Jan 22, 2015, with a Focus on Biopharma Industrial Innovation & International Technology Transfer 3
... historic open letter to the World Health Organization ... Drugs (CoMeD) , and the United Methodist Women are seeking ... vaccines.  Currently, the mercury-based preservative Thimerosal, which is 49% mercury ... much of the world, despite the fact that it is ...
... Texas, March 15, 2012  OxySure® Systems, Inc. (OTCBB: ... emergency oxygen solutions with its "oxygen from powder" ... a Supplier Agreement ("Agreement") with W.W. Grainger, Inc. ... (Logo:  http://photos.prnewswire.com/prnh/20120315/DA71084LOGO ) In terms ...
Cached Medicine Technology:Global Call for Mercury-free Vaccines Issued 2OxySure Systems Announces Supplier Agreement With Grainger 2OxySure Systems Announces Supplier Agreement With Grainger 3
(Date:11/21/2014)... Recently, TideStore.com, a leading online store offering many ... offer TideStore Thanksgiving Sales . According to the ... provided with big discounts. The special offer is valid ... extra 10% discount with this coupon code: thanks. , ... opportunities to win free gifts. TideStore.com has done much ...
(Date:11/21/2014)... CARE Surrogacy Center in Mexico is ... at the same time enhancing their surrogacy journey with high ... parents across the globe, the company is reporting on its ... zoning in on the skyrocketing costs of surrogacy — and ... over-stressing clinical success rates ? , Fertility clinics ...
(Date:11/21/2014)... TX (PRWEB) November 21, 2014 ... facility at 7am today. The new facility is located ... open 24-7. , “We are pleased to join ... highest quality emergency medical care here,” said Dr. Siddiqi, ... , To celebrate the opening, First Choice ...
(Date:11/21/2014)... Maureen Salamon HealthDay Reporter ... Jobs requiring intellectually challenging tasks may help preserve thinking ... suggests. The researchers compared IQ scores obtained ... with their memory and reasoning scores around age 70. ... jobs appeared to retain sharper thinking even years after ...
(Date:11/21/2014)... (HealthDay News) -- Some people with cochlear implants experience ... when they undergo an MRI scan, a new study ... researchers, about 300,000 people worldwide have cochlear implants, devices ... are deaf or have severe hearing loss. There have ... implants when undergoing MRI. One expert said the ...
Breaking Medicine News(10 mins):Health News:Thanksgiving Sales from TideStore.com 2Health News:CARE Surrogacy Center Reports on its Multiple Measures of Success 2Health News:CARE Surrogacy Center Reports on its Multiple Measures of Success 3Health News:First Choice Emergency Room Opens New Facility in Friendswood, Texas 2Health News:Could Your Job Help Preserve Your Aging Brain? 2Health News:Could Your Job Help Preserve Your Aging Brain? 3Health News:MRI Can Be Painful, Disruptive for People With Cochlear Implants 2
... brain, study suggests , , WEDNESDAY, Aug. 22 (HealthDay News) ... traumatic memories go so deep and linger so long ... shows that a powerful neurochemical called norepinephrine is released ... it also "imprints" an emotional fear tagged to the ...
... it prevented buildup of dangerous tau protein , , TUESDAY, ... combat a protein implicated in Alzheimer,s disease has proven ... protein accumulates into damaging tangles in the memory center ... at the New York University Medical Center (NYUMC). , ...
... , TUESDAY, Aug. 21 (HealthDay News) -- Claims of male-female ... or validation, experts report in the Aug. 22/29 issue of ... A team of researchers in Greece analyzed 77 studies that ... percent) of these claims were decided in advance of the ...
... three-quarters of cases went unnoticed, study found , , TUESDAY, ... one in four children who had high blood pressure ... the dangerous problem is missed. , "Hypertension in children ... a pediatrician, internist and fellow at the Center for ...
... major study finds , , TUESDAY, Aug. 21 (HealthDay News) -- ... cancer and acrylamide, a substance found in many baked and ... subject conducted to date. , "The data are accumulating, and ... to be an important breast cancer risk factor," said study ...
... the behavioral and academic problems associated with Attention Deficit ... by researchers at Lehigh Universitys College of Education. , ... National Institute of Mental Health (NIMH), was the largest ... 5 who have shown significant symptoms of ADHD. It ...
Cached Medicine News:Health News:Study Probes Roots of Fearful Memories 2Health News:Gene Studies of Male-Female Differences Often Flawed 2Health News:Doctors Often Miss High Blood Pressure in Kids 2Health News:Doctors Often Miss High Blood Pressure in Kids 3Health News:Acrylamide Won't Raise Breast Cancer Risk 2Health News:Acrylamide Won't Raise Breast Cancer Risk 3Health News:Acrylamide Won't Raise Breast Cancer Risk 4Health News:Non-medicinal treatment touted for pre-schoolers with ADHD 2Health News:Non-medicinal treatment touted for pre-schoolers with ADHD 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: